 Home > Medical News > Medical Research Articles > Genting Sunshine and Providence Therapeutics jointly announced a vaccine development strategy against the Omicron (B.1.1.529) variant of the new coronavirus

Genting Sunshine and Providence Therapeutics jointly announced a vaccine development strategy against the Omicron (B.1.1.529) variant of the new coronavirus

 Last Update: 2022-01-02
 Source: Internet
 Author: User

Tags

rapid prototyping manufacturing

manufacturing

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Scientists from the two companies have analyzed the sequence of the Omi Keron mutant strain of the new coronavirus, obtained the virus sequence, and designed plasmid clones

"We believe that the rapid and effective development of new vaccines against the new variant of the new coronavirus Omi Keron is crucial

"We look forward to working with Providence to quickly develop a new vaccine against the Omi Keron variant of the new coronavirus and allow people to benefit from it, especially in areas where the current mRNA vaccination rate is relatively low

About Providence Therapeutics

Providence is a leading Canadian biotechnology company in the clinical stage and a pioneer in the development of mRNA drugs and vaccines, with operations in Calgary, Alberta and Toronto, Ontario

About Genting Shinyao

Genting Xinyao is a biopharmaceutical company focused on the development and commercialization of innovative drugs, dedicated to meeting the unmet medical needs of emerging Asian markets

Forward-looking statements

This press release contains forward-looking statements as defined by applicable securities laws, including statements regarding Providence’s potential vaccine development against COVID-19

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Neopentyl Glycol CAS NO.126-30-7 99% High Quality Factory Supply

CAS No.: 126-30-7

Industrial Grade

$1.7-2/KG FOB

Factory Supply Tirzepatide 10 mg 15mg Weight Loss Peptide 10mg 99.9% CAS: 2023788-19-2

CAS No.: 2023788-19-2

Pharmacy Grade

$4-5/UNIT FOB

good quality 2cb wholesale

CAS No.: 58743-75-2

$2-2.2/MT EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.